Rockville , Sept. 14, 2023 (GLOBE NEWSWIRE) -- As per a recent report published by Fact.MR, the global heart valve devices market is poised to grow at a CAGR of 13 % from 2022 to 2032, expected to close at a valuation of US$ 37.5 Billion. Sedentary lifestyles, physical inactivity and other habits such as smoking have induced the prevalence of cardiovascular diseases. Subsequently, the demand for minimally invasive procedures to address cardiac anomalies have increased substantially across the globe.
From 2015 to 2021, the market for heart valve devices grew at a CAGR of 13.1%, closing at a value of US$ 9.85 Billion. As of 2022, the industry is likely to reach US$ 11.16 Billion. Prospects heightened after the increasing awareness and soaring cases of cardiac problems like stroke, blood clots in developing countries.
Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=4759
Government policies lay emphasis on providing better healthcare infrastructure and better treatment for its citizens. Thereby, increment in the healthcare budget in several countries is boosting the demand for the transcatheter heart valve devices. Biological Heart Valve Devices increases the life expectancy and reduces the chances of heart attacks which will help in gaining new market grounds for prominent manufacturers.
| Report Attributes | Details |
| Value Projection (2032) | US$ 37.5 Billion |
| Growth Rate (2022-2032) | 13 % CAGR |
| No. of Pages | 170 pages |
| No. of Tables | 80 Tables |
| No. of Figures | 47 Figures |
Key Takeaways from the Market Study
- Global heart valve devices market to flourish 2.6x from 2022-2032
- Transcatheter heart valve devices to be a top-selling category, capturing more than 42% market and flourishing at a 17% CAGR until 2032
- By type, Biological heart valve devices is likely to expand at a CAGR of 8%
- U.S to emerge as the fastest-growing heart valve devices market, documenting a 13.7% CAGR
- China to be the 2nd most opportunistic market, expected to be valued at US$ 18.5 Billion in 2032
"Technological progressions, increasing geriatric population, and an upsurge in prevalence of heart valve disorders (mitral regurgitation and aortic stenosis), and rise in minimally invasive techniques demand to bolster demand for prosthetic devices for heart," comments a Fact.MR analyst.
Key Companies Profiled In this Report
- Edwards Lifesciences Corporation
- Braile Biomedica
- St. Jude Medical Inc.
- Medical Technology Est.
- Micro Interventional Devices Inc.
- Boston Scientific Corporation
- Liva Nova PLC
- Cryolife, Inc.
- Jena Valve Technology Inc.
Competitive Landscape
The global market for heart valve devices is characterized by the presence of multiple vendors, aiming to offer extensive consulting and integration services to clients. Additionally, enterprises are seeking out, specialized service providers, offering solutions tailor-made to suit their business objectives. In addition, the vendors are likely to leverage up-gradation and product differentiation to gain an edge over other competitors in the market.
- In March 2022, Edwards Lifesciences Corporation received approval from the U.S. Food and Drug Administration (FDA) for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart's mitral position.
- In January 2022, CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, made an announcement of renaming and rebranding itself to Artivion, Inc., effective immediately. Derived from the word's "aorta", "innovation", and "vision", the company's new name and brand reflect its evolution to focus on providing innovative technologies to surgeons who treat patients with aortic disease.
Key Segments Covered in the Heart Valve Devices Industry Survey
- Heart Valve Devices by Type
- Mechanical Heart Valves
- Aortic Valve
- Mitral Valve
- Biological Heart Valve
- Aortic Valve
- Mitral Valve
- Pulmonary Valve
- Tricuspid Valve
- Transcatheter Valves
- Aortic Valve
- Mitral Valve
- Pulmonary Valve
- Mechanical Heart Valves
- Heart Valve Devices by End User
- Hospitals
- Ambulatory Surgical Centers
- Heart Valve Devices by Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4759
More Valuable Insights
Fact.MR, in its new offering, presents an unbiased analysis of the global heart valve devices market, presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032.
The study reveals essential insights on the basis of type (mechanical heart valves, biological heart valve and transcatheter valves) and end-user (hospitals and ambulatory surgical centers) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).
Explore More Related Studies Published by Fact.MR Research:
Heart Attack Diagnostics Market: Global demand for heart attack diagnostics is projected to reach US$ 23.8 Billion by 2032.
Heart Monitoring Devices Market: Worldwide demand for heart monitoring devices is forecasted to increase at a CAGR of 6% from 2023 to 2033.
Heart Rate Monitor Watch Market: global sales of heart rate monitor watches are expected to reach US$ 36.6 billion by 2032.
About Fact.MR:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we delivers deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empowers businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
